FILE PHOTO: A nurse shows a Hydroxychloroquine pill, amid the coronavirus disease (COVID-19) outbreak, at Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, April 23, 2020. REUTERS/Diego Vara
(Reuters) – Malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking, was tied to increased risk of death in a study in 96,000 COVID-19 patients, according to a paper published in the Lancet.
The study found here that people treated with hydroxychloroquine, or the closely related drug chloroquine, had higher risk of in-hospital death when compared to those who had not been given the drug.
Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty
Our Standards:The Thomson Reuters Trust Principles.
This article was originally published by Reuters.com. Read the original article here.
English 
Azerbaijani